Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Efficient Non-Epigenetic Activation of HIV Latency through the T-Cell Receptor Signalosome

Viruses(2020)10.3390/v12080868Source: DataRank Database

Efficient Non-Epigenetic Activation of HIV Latency through the T-Cell Receptor Signalosome is a research paper published in Viruses (2020). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.88)OA: goldTopics (67)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Adhikarimayum Lakhikumar Sharma,Mudit Tyagi ORCID,Joseph Hokello ORCID

Live enrichment

PubMed:32784426 PMC:PMC7472175 OpenAlex:https://openalex.org/W3047664661

Fogarty International Center

Grant: AIDS International Training and Research Program (AITRP) at Case Western Reserve UniversityTraining Grant: #464 NIH 5D43 TW00011 to JH

National Institutes of Health

Grant: 1R01DA041746-01 to M.T.

NIDA NIH HHS

Grant: R01 DA041746

National Institutes of Health

Grant: 3D43TW000011-05S1

CLINICAL AND LABORATORY TRAINING--U S AND UGANDA

National Institutes of Health

Grant: 1R01DA041746-01

Characterization of cocaine induced signaling pathways that enhances HIV transcription

FWCI

0.88

Citation Percentile

0.7%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1999-4915/12/8/868/pdf?version=1596984411

publisherhttps://www.mdpi.com/1999-4915/12/8/868/pdf?version=1596984411

publisherhttps://www.mdpi.com/1999-4915/12/8/868/pdf

journalhttps://doi.org/10.3390/v12080868

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32784426

Fields of Study

HIV Research and TreatmentImmune Cell Function and InteractionHIV/AIDS drug development and treatment0301 basic medicine03 medical and health sciencesCD4-Positive T-LymphocytesHIV InfectionsHIV Long Terminal RepeatHIV-1HumansNF-kappa BNFATC Transcription FactorsReceptors, Antigen, T-CellSignal TransductionTranscription Factor AP-1Transcription, GeneticVirus Latency

MeSH Terms

HumansReceptors, Antigen, T-CellTranscription, GeneticSignal TransductionCD4-Positive T-LymphocytesHIV-1HIV InfectionsHIV Long Terminal RepeatNF-kappa BVirus LatencyTranscription Factor AP-1NFATC Transcription Factors

Keywords

BiologyP-TEFbEpigeneticsNFATTranscription factorCell biologyHIV Long Terminal RepeatVirus latencyMolecular biologyLong terminal repeatPromoterGeneticsViral replicationGene expressionCell cultureHIVTranscription factorsReactivationLatencyNon-epigeneticsCD4-Positive T-LymphocytesTranscription, GeneticReceptors, Antigen, T-Cell610HIV InfectionsReviewMicrobiologyMedicine and Health SciencesHumansTranslational Medical ResearchNFATC Transcription FactorsNF-kappa BCenter for Translational MedicineQR1-502Transcription Factor AP-1Thomas Jefferson UniversityHIV-1Signal Transduction

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being